Is It Too Late To Consider Herbalife (HLF) After A 142% One Year Rally?

• Investors may be considering whether Herbalife at around US$16.44 is still priced attractively or if much of the opportunity has already been reflected in the stock.
• The share price performance has been strong recently, with returns of 2.9% over 7 days, 15.2% over 30 days, 28.2% year to date and 142.1% over the past year, compared with 19.7% over 3 years and a 66.4% decline over 5 years.
• Recent coverage has focused on Herbalife's position in the personal products sector, ongoing attention on the direct selling model, and how shifting consumer preferences may affect longer term demand. This context helps frame why the stock's recent performance looks very different over shorter and longer time frames.
• Herbalife currently has a 5/6 valuation score. The next sections will walk through the key valuation methods behind that figure and will also point to a broader way of thinking about value that ties everything together at the end.

Herbalife delivered 142.1% returns over the last year. See how this stacks up to the rest of the Personal Products industry.

Approach 1: Herbalife Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting future cash flows and then discounting them back to today using a required rate of return. It is essentially asking what future dollars are worth in today’s terms.

For Herbalife, the model used is a 2 Stage Free Cash Flow to Equity approach. The company’s last twelve months Free Cash Flow is about $220.7 million, and Simply Wall St then applies analyst estimates where available and extrapolates further cash flows beyond that period. For example, projected Free Cash Flow for 2024 is $162 million, and the model extends out to 2035 with a series of annual cash flow projections expressed in millions of dollars.

When all of those projected cash flows are discounted back to today, the resulting estimated intrinsic value comes out at about $30.26 per share. Compared with the recent share price of around $16.44, this DCF output suggests the stock is currently priced at a 45.7% discount to that intrinsic value. This indicates a material gap between the current market price and the model’s assessment of value.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Herbalife is undervalued by 45.7%. Track this in your watchlist or portfolio, or discover 47 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Herbalife.

Approach 2: Herbalife Price vs Earnings

For profitable companies, the P/E ratio is a useful way to relate what you pay for the stock to the earnings it currently generates. Investors usually expect higher growth and lower risk to justify a higher, or “richer”, P/E ratio. In contrast, slower growth or higher risk tends to line up with a lower, more cautious P/E.

Herbalife trades on a P/E of 7.45x. This sits well below the Personal Products industry average P/E of 19.98x and also below a peer group average of 16.46x. Those comparisons suggest the stock is priced more conservatively than many peers in the same sector.

Simply Wall St’s Fair Ratio for Herbalife is 15.50x. This is a proprietary P/E estimate that reflects factors such as the company’s earnings growth profile, its industry, profit margins, market capitalization and key risks. Because it adjusts for these company specific characteristics rather than relying only on broad peer or industry averages, it aims to be a more tailored benchmark for what might be a reasonable multiple.

Comparing Herbalife’s current P/E of 7.45x with the Fair Ratio of 15.50x suggests the stock is trading below that tailored benchmark.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Herbalife Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you attach a clear story about Herbalife, including your own fair value, revenue, earnings and margin assumptions, to a forecast that the platform tracks in real time as news or earnings arrive. It then compares your Fair Value with the live share price so you can judge for yourself whether the stock looks attractive or stretched. This is why one investor on the Community page might build a more cautious Herbalife Narrative that aligns with a US$9 fair value, while another builds a more optimistic Narrative closer to US$25, both using the same tools but different views about future growth, margins, risks and appropriate P/E multiples.

For Herbalife, however, we will make it really easy for you with previews of two leading Herbalife Narratives:

🐂 Herbalife Bull Case

Fair value in this bullish narrative: US$17.50 per share

Implied discount to that fair value at US$16.44: about 6.1%

Revenue growth assumption: 3.85% a year

• Analysts in this camp expect steady but moderate revenue growth, with profit margins rising from 4.5% to 5.7% over the next few years.
• The narrative weighs regulatory and consumer preference risks, but sees Herbalife's focus on wellness products, technology, and distributor engagement as supportive for earnings and cash flow.
• It anchors on a consensus Fair Value of US$17.50, while highlighting that analyst targets range widely from US$9.00 to US$25.00, so your view on regulation, demand and execution really matters.

🐻 Herbalife Bear Case

Fair value in this bearish narrative: US$9.00 per share

Implied premium to that fair value at US$16.44: about 82.7%

Revenue growth assumption: 2.82% a year

• This narrative focuses on the risk that tighter regulation, changing consumer tastes and distributor challenges could keep pressure on Herbalife's model.
• It incorporates slower revenue growth and a lower future P/E of 4.3x, alongside concerns about debt levels and the ability to sustain volume growth without relying heavily on pricing.
• The conclusion is that, on these assumptions, a Fair Value of US$9.00 leaves current pricing looking stretched, so the balance between execution risk, competition and leverage is central.

If you want to move from these previews to a full, trackable story that reflects your own assumptions rather than anyone else's, the easiest next step is to compare and customize the community narratives for Herbalife in one place using See what the community is saying about Herbalife.

Do you think there's more to the story for Herbalife? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com